FDA Clearance Tracker · K222065
Passeo-35 Xeo Peripheral Dilatation Catheter
Last checked: Nov 19, 2026Latest source record: Feb 16, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Feb 16, 2023
Substantially Equivalent
Time to decision
218 days
Received Jul 13, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K222065
- Device name
- Passeo-35 Xeo Peripheral Dilatation Catheter
- Applicant
- Biotronik, Inc.
- Applicant location
- Lake Oswego, OR
- Received
- Jul 13, 2022
- Decided
- Feb 16, 2023
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.1250
- Specialty
- CardiologyInterventional Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LIT. The earliest in FDA's data is K803057, decided Jan 13, 1981.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K222065
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Biotronik, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- BIOMONITOR IV (471155)510(k)
K261074 · Decided May 1, 2026 · 30 days after receipt
Device type: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD) · Cardiology
K250706 · Decided Apr 4, 2025 · 25 days after receipt
Device type: Catheter, Angioplasty, Peripheral, Transluminal (LIT) · Cardiology
- Pantera Pro; Pantera LEO510(k)
K242969 · Decided Oct 25, 2024 · 29 days after receipt
Device type: Catheters, Transluminal Coronary Angioplasty, Percutaneous (LOX) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.